DexCom, Inc. (DXCM)

NASDAQ: DXCM · IEX Real-Time Price · USD
117.21
+3.28 (2.88%)
At close: Mar 20, 2023, 4:00 PM
117.88
+0.67 (0.57%)
Pre-market: Mar 21, 2023, 6:38 AM EDT
2.88%
Market Cap 45.29B
Revenue (ttm) 2.91B
Net Income (ttm) 341.20M
Shares Out 386.41M
EPS (ttm) 0.82
PE Ratio 142.94
Forward PE 120.48
Dividend n/a
Ex-Dividend Date n/a
Volume 1,319,699
Open 113.95
Previous Close 113.93
Day's Range 113.95 - 117.43
52-Week Range 66.89 - 134.77
Beta 1.09
Analysts Buy
Price Target 135.40 (+15.52%)
Earnings Date Apr 27, 2023

About DXCM

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is ... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Apr 14, 2005
Employees 6,300
Stock Exchange NASDAQ
Ticker Symbol DXCM
Full Company Profile

Financial Performance

In 2022, DexCom's revenue was $2.91 billion, an increase of 18.84% compared to the previous year's $2.45 billion. Earnings were $341.20 million, an increase of 57.31%.

Financial Statements

Analyst Forecast

According to 27 analysts, the average rating for DXCM stock is "Buy." The 12-month stock price forecast is $135.4, which is an increase of 15.52% from the latest price.

Price Target
$135.4
(15.52% upside)
Analyst Consensus: Buy
Stock Forecasts

News

DexCom Comments on SVB Relationship

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a recent CNBC arti...

1 week ago - Business Wire

Silicon Valley Bank signed exclusive banking deals with some clients, leaving them unable to diversify

Silicon Valley Bank required some clients to agree to exclusivity clauses, disabling them from diversifying where they held their money, SEC records show.

Other symbols: DOCUEGIOSIVBSPTUPST
1 week ago - CNBC

5 Stocks That Powered Nasdaq ETF Last Week

The tech-heavy Nasdaq Composite Index outperformed last week, gaining 2.6%, while the S&P 500 and the Dow Jones were up 1.9% and 1.7%, respectively.

Other symbols: ADBEALGNTEAMVRSK
2 weeks ago - Zacks Investment Research

Dexcom Announces Upcoming Conference Presentations

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences: Sean Christensen, Vice Pres...

3 weeks ago - Business Wire

Dexcom drops on report that Apple has made glucose tracking breakthrough

A new breakthrough by Apple could be bad news for medical device company Dexcom. With CNBC's Melissa Lee and the Fast Money traders, Karen Finerman, Dan Nathan, Courtney Garcia and Guy Adami.

3 weeks ago - CNBC Television

Dexcom shares fall on news Apple is progressing on glucose tracking for watch

CNBC's Steve Kovach joins the 'Halftime Report' to report on Dexcom shares dropping on news that Apple is making progress on including a glucose tracking feature on the Apple Watch.

3 weeks ago - CNBC Television

Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally

SAN DIEGO--(BUSINESS WIRE)-- #Dexcom--Dexcom Showcases Accuracy, Simplicity and Connectivity of its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally

3 weeks ago - Business Wire

Dexcom G6 Continuous Glucose Monitoring System Launches in Singapore

SINGAPORE--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of its Dexcom G6 CGM Syste...

3 weeks ago - Business Wire

Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch

SAN DIEGO--(BUSINESS WIRE)---- $DXCM #CGM--Dexcom G7 Continuous Glucose Monitoring System Will be Available to Medicare Beneficiaries at Launch

1 month ago - Business Wire

Dexcom CEO on working with insurance companies

Cramer spoke with Dexcom CEO Kevin Sayer on Friday.

1 month ago - CNBC Television

DexCom (DXCM) Q4 Earnings Beat Estimates, Volumes Remain Strong

DexCom's (DXCM) fourth-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.

1 month ago - Zacks Investment Research

DexCom (DXCM) Tops Q4 Earnings and Revenue Estimates

DexCom (DXCM) delivered earnings and revenue surprises of 30.77% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results

SAN DIEGO--(BUSINESS WIRE)---- $DXCM #cgm--Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results

1 month ago - Business Wire

Dario Partners to Integrate Dexcom CGM Data

New integration will improve access to Dario's multi-chronic platform for more people living with diabetes NEW YORK , Feb. 8, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a l...

Other symbols: DRIO
1 month ago - PRNewsWire

Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System

Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System

1 month ago - Business Wire

Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom

TORONTO--(BUSINESS WIRE)--Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW) (OTCQX: MDNWF) announced today the launch of its enhanced Virtual Diabetes Management program, an end-to-end digital di...

1 month ago - Business Wire

Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2022 financial results after market close on Thursday, February 9, 20...

1 month ago - Business Wire

The Top 7 “Millionaire-Maker” Long-Term Stocks for 2023

Study after study shows that a long-term buy-and-hold investing strategy works best. A long-term investment is generally defined as any position in a stock that is held for a year or longer.

2 months ago - InvestorPlace

Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), is pleased to announce that coverage for Dexcom G6 rtCG...

2 months ago - Business Wire

DexCom (DXCM) Announces Solid Preliminary Q4 Revenues

DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its CGM sales.

2 months ago - Zacks Investment Research

Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), the leader in real-time continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth q...

2 months ago - Business Wire

Dexcom Appoints Teri Lawver as Chief Commercial Officer

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the appointment of Teri Lawver to the ...

2 months ago - Business Wire

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio (Revised)

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

2 months ago - Zacks Investment Research

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

2 months ago - Zacks Investment Research

Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 41st annual J.P...

2 months ago - Business Wire